期刊文献+

复治肺结核患者耐多药的影响因素分析 被引量:4

Research of factors influencing on the multi-drug resistant of recurrenttuberculosis patients
下载PDF
导出
摘要 目的:探讨复治肺结核患者耐多药的影响因素。方法130例复治耐多药肺结核患者纳入研究组,110例复治非耐多药肺结核患者纳入对照组。比较2组患者年龄、性别、文化程度、结核病灶数、婚姻状况、体质量、第一次抗结核治疗持续时间、接受抗结核药治疗次数、病变累加肺野数、最近一次治疗结局等资料。结果2组患者年龄、文化程度、户籍、结核病灶数、病变累加肺野数、第一次抗结核治疗持续时间、接受抗结核药物治疗次数、最近一次抗结核治疗结局比较差异均有统计学意义(P<0.05)。年龄(OR =1.160,95% CI :1.051~1.310)、文化程度(OR =3.142,95% CI :1.621~5.912)、户籍(OR =3.136,95% CI :1.617~5.827)、结核病灶个数(OR =2.989,95% CI :1.218~4.298)、最近一次治疗结局(OR =1.282,95% CI :1.019~2.296)、第一次抗结核治疗持续时间(OR =1.316,95% CI :1.216~1.579)、接受抗结核药物治疗次数(OR =1.361,95% CI :1.071~1.721)、病变累加肺野数(OR =1.796,95% CI :1.516~2.619)等因素和复治耐多药肺结核发病密切相关,是其主要影响因素。结论年龄、文化程度、结核病灶数、最近一次治疗结局、第一次抗结核治疗持续时间、接受抗结核药物治疗次数是复治耐多药肺结核发病的主要影响因素,对以上高危人群应做好肺结核耐多药的防治工作,以减少肺结核耐多药的发生率。 Objective To study factors influencing on the multi‐drug resistant of recurrent tuberculosis patients .Methods A to‐tal of 130 recurrent multi‐drug resistant tuberculosis patients were selected into study group ,and 110 recurrent tuberculosis patients without multi‐drug resistant were selected into control group .Data such as age ,gender ,educational level ,number of tuberculosis fo‐cus ,marital status ,weight ,anti‐tuberculosis treatment for the first time duration ,number of anti‐tuberculosis drug treatment ,lesion accumulation number of lung field ,the latest treatment outcome and so on in the two groups were compared retrospectively .Results Age ,culture level ,household registration ,the number of tuberculosis focus ,lesion accumulation number of lung field ,anti‐tuber‐culosis treatment for the first time duration ,number of anti‐tuberculosis drugs therapy ,a recent anti‐tuberculosis treatment outcome in the two groups were all significant different(P〈 0 .05) .Age (OR = 1 .160 ,95% CI :1 .051 - 1 .310) ,education (OR = 3 .142 ,95%CI :1 .621 - 5 .912) ,household registration (OR = 3 .136 ,95% CI :1 .617 - 5 .827) ,the number of tuberculosis focus (OR = 2 .989 , 95% CI :1 .218 - 4 .298) ,the latest treatment outcome (OR= 1 .282 ,95% CI :1 .019 - 2 .296) ,the first anti‐tuberculosis treatment duration (OR = 1 .316 ,95% CI :1 .216 - 1 .579) ,and treated with anti‐tuberculosis drugs number (OR = 1 .361 ,95% CI :1 .071 -1 .721) ,the number of lesion accumulation lung field (OR = 1 .796 ,95% CI :1 .516 - 2 .619) were closely related with the recurrent of multi‐drug resistant tuberculosis incidence ,as the main influencing factors .Conclusion Age ,culture level ,the number of tuber‐culosis focus ,the latest treatment outcome ,anti‐tuberculosis treatment duration for the first time ,treated with anti‐tuberculosis drugs number are main influencing factors of the recurrent of multi‐drug resistant tuberculosis .High‐risk groups should do a good job of prevention and control of multi‐drug resistant tuberculosis ,in order to reduce the incidence of multi‐drug resistant tuberculosis .
出处 《国际检验医学杂志》 CAS 2015年第11期1568-1570,共3页 International Journal of Laboratory Medicine
关键词 复治肺结核 耐多药 影响因素 相关性 recurrent tuberculosis multi-drug resistant influence factors correlation
  • 相关文献

参考文献15

二级参考文献131

共引文献2537

同被引文献57

  • 1陈亮,周琳,尹建军,吴惠忠,蒋莉,钟球.耐多药结核病的筛查效果及危险因素分析[J].结核病与肺部健康杂志,2012,1(2). 被引量:6
  • 2宁柱,邓建平,李群,周世熙,陈曦.四川省自贡市2010—2011年耐药结核病社会人口学和临床影响因素研究[J].结核病与肺部健康杂志,2012,1(2). 被引量:3
  • 3陆兰英,王卫华,曾庆志,袁宝东,黄健.武汉地区耐多药结核病危险因素的病例对照研究[J].中国防痨杂志,2005,27(5):340-342. 被引量:15
  • 4G6mez-G6mez A, Maga6a-Aquino M, L6pez-Meza S, et al. Diabetes and other risk factors for muhi-drug resistant tuberculosis in a mexican population with pulmonary tuberculosis : case control study [ J ]. Arch Med Res,2015,46 ( 2 ) : 142-148.
  • 5Ogbera AO,Kapur A,Odeyemi K, et al. Screening for diabetes melli- tus and human immunodefiency virus infection in persons with tuber- culosis[J]. J Prey Med Hyg,2014,55(2) :42-45.
  • 6Chiang CY, Bai KJ, Lin HH, et al. The influence of diabetes, glycemic control,and diabetes-related comorbidities oVL puhnonary tuberculosis [J]. PLoS One,2015,10(3) :e0121698.
  • 7Aggarwal D, Chander J, Janmeja AK, et al. Pulmonary tuberculosis and mucormycosis co-infection in a diabetic patient[ J ]. Lung India, 2015,32( 1 ) :53-55.
  • 8Zhan Y,Jiang L. Status of vitamin D,antimicrobial peptide cathelicidin and T helper-associated cytokines in patients with diabetes mellitus and pulmonary tuberculosis [ J ]. Exp Ther Med ,2015,9( 1 ) :11-16.
  • 9Kumar NP, Sridhar R, Nair D, et al. Type 2 diabetes mellitus is asso- ciated with altered CD8 ( + ) T and natural killer cell function in pul- monary tuberculosis[ Jl. Immunology,2015,144(4) :677-686.
  • 10朱建福,王伟炳,王学才,范建良,胡芬芳,沈伟,陈峰,王法弟,徐飚.德清县耐药肺结核流行情况及危险因素研究[J].浙江预防医学,2009,21(9):6-8. 被引量:13

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部